Dr. Carlos FloresM.D.

Family Medicine

at Transcend Medical Group — Arlington, TX

About

Dr. Carlos Flores trained at McGovern Medical School and brings extensive experience in family medicine to Transcend Medical Group. He provides comprehensive care to diverse patient populations, addressing both acute health needs and long-term wellness. Dr. Flores is fluent in Spanish and puts patient-centered communication at the heart of every visit. His clinical work reflects a deep commitment to cultural competence, ensuring each patient receives care that respects their individual background and context.

Education & Training

Medical School

McGovern Medical School

Languages

Spanish

Who is Dr. Flores right for?

Dr. Flores is an excellent fit for Spanish-speaking patients who want a bilingual physician. He serves diverse patient populations and brings cultural competence to every interaction. Patients looking for a family medicine doctor who addresses both immediate health concerns and broader wellness goals will find strong alignment with Dr. Flores.

Similar Doctors Nearby

Frequently Asked Questions

Yes. Dr. Flores is fluent in Spanish. He prioritizes clear, culturally competent communication and sees language as a core part of effective patient care.

Dr. Flores specializes in Family Medicine. He provides comprehensive care that covers both acute illness and preventive health, serving patients across a wide range of backgrounds.

Dr. Flores earned his medical degree from McGovern Medical School. He has since built extensive experience serving diverse communities in family medicine.

Dr. Flores focuses on patient-centered communication and cultural competence. He believes that making a real difference in patient well-being requires understanding the individual, not just the condition.

Dr. Flores sees patients across a wide range of ages and backgrounds. He is particularly experienced in caring for diverse communities and patients who benefit from Spanish-language communication.

Doctor profile last updated June 9, 2026